- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Immobilier
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Actualités 1062 results
Client Alert
janvier 13, 2025
FDA Finalizes Guidance on Scientific Information on Unapproved Uses (SIUU)
Article
janvier 13, 2025
Outlook 2025: Look for MA Cases Based on Claim Denials; Incoming DOJ May Tweak Guidance
Client Alert
janvier 13, 2025
FTC Announces 2025 Jurisdictional Threshold Updates for Interlocking Directorates and HSR Filing Thresholds
Client Alert
janvier 10, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
Thought Leadership
janvier 10, 2025
Why Corporate Whistleblower Programs May Need a Refresh
Article
janvier 10, 2025
Proposed CMS Rule on Behavioral Health Cost-Sharing: Opportunity for Plans and Providers to Comment
Client Alert
janvier 9, 2025
Record “Gun Jumping” Penalty Imposed by FTC
Client Alert
janvier 9, 2025
When Mentors and Loved Ones Are Dangerous: Avoid Insider Trading Charges with a 2025 New Year's Resolution
Client Alert
janvier 7, 2025
DOJ Issues Final Rule Restricting Foreign Access to U.S. Data
Client Alert
janvier 6, 2025
Proposed Changes to FARA Will Result in More Questions than Answers
Client Alert
janvier 6, 2025
FDA Issues Draft Guidance on Accelerated Approval Focused on How the Agency Will Implement New Authorities